topamax 15 mg capsule
janssen-cilag ag - topiramatum - capsule - topiramatum 15 mg, sacchari sphaerae, povidonum k 30, cellulosi acetas, kapselhülle: gelatina, e 171 pro capsula. - farmaco antiepilettico, migräneprophylaxe - synthetika
topamax 50 mg capsule
janssen-cilag ag - topiramatum - capsule - topiramatum 50 mg, sacchari sphaerae, povidonum k 30, cellulosi acetas, kapselhülle: gelatina, e 171 pro capsula. - farmaco antiepilettico, migräneprophylaxe - synthetika
benylin mit codein sirup
janssen-cilag ag - diphenhydramini hydrochloridum, codeini phosphas hemihydricus - sirup - diphenhydramini hydrochloridum 14 mg, codeini phosphas hemihydricus 5.7 mg, levomentholum, saccharum 999 mg, glucosum liquidum 3.49 g, ethanolum 96 per centum 0.259 ml, glycerolum, natrii citras dihydricus, saccharinum natricum, acidum citricum monohydricum, aqua purificata, aromatica, e 124 0.25 mg, e 150(a), e 211 10 mg ad solutionem pro 5 ml corresp. ethanolum 5 % v/v et natrium 16.65 mg. - tosse stizzosa - synthetika
tracleer 62,5 mg compresse rivestite con film
janssen-cilag ag - bosentanum - compresse rivestite con film - bosentanum 62.5 mg ut bosentanum monohydricum, maydis amylum, amylum pregelificatum, carboxymethylamylum natricum a corresp. natrium 0.1575 mg, povidonum k 90, glyceroli dibehenas, magnesii stearas, Überzug: hypromellosum, triacetinum, talcum, ethylcellulosum, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto. - primaria e secondaria di ipertensione polmonare; sclerosi sistemica attiva digitale ulzerationserkrankung - synthetika
tracleer 125 mg compresse rivestite con film
janssen-cilag ag - bosentanum - compresse rivestite con film - bosentanum 125 mg ut bosentanum monohydricum 129.082 mg, maydis amylum, amylum pregelificatum, carboxymethylamylum natricum a corresp. natrium 0.315 mg, povidonum k 90, glyceroli dibehenas, magnesii stearas, Überzug: hypromellosum, triacetinum, talcum, ethylcellulosum, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto. - primaria e secondaria di ipertensione polmonare; sclerosi sistemica attiva digitale ulzerationserkrankung - synthetika
concerta 18 mg retardtabletten
janssen-cilag ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 18 mg, macrogolum 200'000, macrogolum 7'000'000, povidonum k 29-32, acidum succinicum, acidum stearicum, e 321, e 172 (flavum), e 172 (nigrum), natrii chloridum corresp. natrium 7.08 mg, cellulosi acetas, poloxamerum 188, hypromellosum, acidum phosphoricum concentratum, Überzug: lactosum monohydricum corresp. lactosum 6.5 mg, hypromellosum, e 171, triacetinum, e 172 (flavum), acidum stearicum, macrogolum 400, cera carnauba, drucktinte: e 172 (nigrum), propylenglycolum, hypromellosum, pro compresso obducto. - centrale efficiente ad azione prolungata - synthetika
concerta 36 mg retardtabletten
janssen-cilag ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 36 mg, macrogolum 200'000, macrogolum 7'000'000, povidonum k 29-32, acidum succinicum, acidum stearicum, e 321, e 172 (flavum), e 172 (nigrum), natrii chloridum corresp. natrium 14.16 mg, cellulosi acetas, poloxamerum 188, hypromellosum, acidum phosphoricum concentratum, Überzug: lactosum monohydricum corresp. lactosum 16.7 mg, hypromellosum, e 171, triacetinum, macrogolum 400, cera carnauba, drucktinte: e 172 (nigrum), propylenglycolum, hypromellosum, pro compresso obducto. - centrale efficiente ad azione prolungata - synthetika
concerta 54 mg retardtabletten
janssen-cilag ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 54 mg, macrogolum 200'000, macrogolum 7'000'000, povidonum k 29-32, acidum succinicum, acidum stearicum, e 321, e 172 (rubrum), e 172 (flavum), e 172 (nigrum), natrii chloridum corresp. natrium 14.16 mg, cellulosi acetas, poloxamerum 188, hypromellosum, acidum phosphoricum concentratum, Überzug: lactosum monohydricum corresp. lactosum 7.6 mg, hypromellosum, e 171, triacetinum, e 172 (rubrum), e 172 (flavum), macrogolum 400, cera carnauba, drucktinte: e 172 (nigrum), propylenglycolum, hypromellosum, pro compresso obducto. - centrale efficiente ad azione prolungata - synthetika
concerta 27 mg retardtabletten
janssen-cilag ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 27 mg, macrogolum 200'000, macrogolum 7'000'000, povidonum k 29-32, acidum succinicum, acidum stearicum, e 321, e 172 (rubrum), e 172 (flavum), e 172 (nigrum), natrii chloridum corresp. natrium 7.08 mg, cellulosi acetas, poloxamerum 188, hypromellosum, acidum phosphoricum concentratum, Überzug: lactosum monohydricum corresp. lactosum 4.9 mg, hypromellosum, e 171, triacetinum, e 172 (nigrum), macrogolum 400, cera carnauba, drucktinte: e 172 (nigrum), propylenglycolum, hypromellosum, pro compresso obducto. - centrale efficiente ad azione prolungata - synthetika
reminyl pr 8 mg capsule
janssen-cilag ag - galantaminum - capsule - galantaminum 8 mg per galantamini hydrobromidum, zucchero sfere corrisp. sintetico 50.9-58.21 mg, ethylcellulosum, hypromellosum, diethylis phthalas, macrogolum 400, kapselhülle: gelatina, e-171, drucktinte: lacca, propylenglycolum, e 172 (nero), una piccola scatola. - da lieve a moderata demenza da malattia di alzheimer di tipo - synthetika